CN Patent
CN109516998B — 一种巴洛沙韦中间体的合成方法
Assigned to Shenzhen Hwagen Pharmaceutical Co ltd · Expires 2021-06-25 · 5y expired
What this patent protects
本发明公开了一种巴洛沙韦中间体的合成方法;属于有机化学合成领域。本发明方法以吡啶酮出发,经脱保护,缩合,手性还原得到巴洛沙韦的关键中间体。本发明的工艺路线简短,条件温和,不需要进行手性拆分即可获得较高的手性纯度,在易于产业化的同时,进一步降低巴洛沙韦的生产成本。
USPTO Abstract
本发明公开了一种巴洛沙韦中间体的合成方法;属于有机化学合成领域。本发明方法以吡啶酮出发,经脱保护,缩合,手性还原得到巴洛沙韦的关键中间体。本发明的工艺路线简短,条件温和,不需要进行手性拆分即可获得较高的手性纯度,在易于产业化的同时,进一步降低巴洛沙韦的生产成本。
Drugs covered by this patent
- Xofluza (BALOXAVIR MARBOXIL) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.